47 results on '"Siefried, Krista J."'
Search Results
2. Understandings, attitudes, practices and responses to GHB overdose among GHB consumers
3. “There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia
4. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review
5. Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not
6. Trends in reported GHB‐related presentations to Sydney emergency departments between 2012 and 2021
7. Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial
8. Playing at the edges, navigating sexual boundaries, and narrating sexual distress; Practices and perspectives of sexuality and gender diverse people who use GHB
9. Controlling for pleasure and risk: The experiences of sexuality and gender diverse people who use GHB
10. Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility Study
11. Impact of the removal of patient co-payments for antiretroviral therapy (ART) on out-of-pocket expenditure, adherence and virological failure among Australian adults living with HIV
12. Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials
13. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
14. Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials.
15. Substance use, socio‐demographic characteristics, and self‐rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study.
16. Methamphetamine and emerging drugs of concern: A training needs analysis of Australian alcohol and other drug helplines.
17. Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019
18. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review
19. Phenobarbital to manage severe gamma‐hydroxybutyrate withdrawal: A case series
20. Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal
21. Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials
22. Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy
23. Barriers to help‐seeking among music festival attendees in New South Wales, Australia
24. Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019.
25. Phenobarbital to manage severe gamma‐hydroxybutyrate withdrawal: A case series.
26. Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials.
27. One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review
28. Correlates of higher‐risk drug‐related behaviours at music festivals in New South Wales, Australia
29. Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder
30. Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019–2020
31. Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019���2020
32. Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study
33. Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019–2020.
34. Characteristics and treatment outcomes of the drug treatment population in New South Wales – focus on amphetamine type stimulants (ATS)
35. A rapid clinical research priority assessment for substance use disorders due to methamphetamine and emerging drugs of concern in Australia
36. Building Australia's Research and Treatment Capacity for Methamphetamine and Emerging Drugs of Concern
37. Correlates of higher‐risk drug‐related behaviours at music festivals in New South Wales, Australia.
38. A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia.
39. Socioeconomic and psychosocial factors are associated with poor treatment outcomes in Australian adults living with HIV: a case-control study
40. Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy
41. Socioeconomic and psychosocial factors are associated with poor treatment outcomes in Australian adults living with HIV: a case-control study
42. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
43. Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019-2020
44. Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.
45. Effect of a Smartphone App (S-Check) on Actual and Intended Help-Seeking and Motivation to Change Methamphetamine Use Among Adult Consumers of Methamphetamine in Australia: Randomized Waitlist-Controlled Trial.
46. Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia.
47. Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.